Chan Mitchell 4
4 · REGENXBIO Inc. · Filed Sep 18, 2024
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Chan Mitchell
Chief Financial Officer
Transactions
- Award
Stock Options (Right to buy)
2024-09-16+289,362→ 289,362 totalExercise: $12.74Exp: 2034-09-16→ Common Stock (289,362 underlying) - Award
Common Stock
2024-09-16+58,869→ 58,869 total
Footnotes (2)
- [F1]The restricted stock unit (RSU) award vesting commencement date shall be September 16, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer.
- [F2]The option vesting commencement date shall be September 16, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer. The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter.